Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Tempest Therapeutics, Inc.

NASDAQ: TPST · Life Sciences · 12 alerts · CIK 1544227

Share price
$0.3418Close, Nov 16
Market cap
$6.83M
Shares outstanding
20MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Tempest Therapeutics, Inc. filings on SEC EDGAR ↗

5:28 PM ET 8-K
Financial Results

Tempest Therapeutics Financial Results

Tempest Therapeutics reported third quarter 2026 financial results and provided a business update on its in vivo CAR-T pipeline, including the lead candidate TPST-4903. During the quarter, the company exercised its option for an exclusive license to Senlang's CD7-targeted platform and secured access to capital through a $50 million equity line of credit and a $2.5 million private placement.

“The third quarter marked a period of meaningful progress in the advancement of two next-generation in vivo CAR-T platforms with the potential to transform treatment across multiple diseases.”

Matt Angel, Ph.D., president and chief executive officer of Tempest

“We made important strides in expanding our pipeline and strengthening our position in the rapidly evolving in vivo CAR-T landscape through our strategic collaboration with Senlang by obtaining exclusive license rights to our clinical-stage BCMA/GPRC5D in vivo CAR-T candidate TPST-4903, while securing access to additional capital to support our development priorities.”

Matt Angel, Ph.D., president and chief executive officer of Tempest
5:26 PM ET 10-Q
Financial Results

Tempest Therapeutics Q3 2026 Results: Net Loss of $3.63M, Loss Widens

Tempest Therapeutics filed its Q3 2026 10-Q reporting 19,995,358 shares of common stock outstanding as of November 13, 2026. The company is focused on advancing its clinical-stage programs, including TPST-4003 and TPST-2003, while addressing substantial risks regarding its ability to continue as a going concern and maintain Nasdaq listing compliance.

Key figure
Net loss $3.63M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.